177 related articles for article (PubMed ID: 11811787)
41. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
42. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.
Aggarwal S; Tsuruo T; Gupta S
J Clin Immunol; 1997 Nov; 17(6):448-54. PubMed ID: 9418184
[TBL] [Abstract][Full Text] [Related]
43. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
44. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
45. HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases.
Blancheteau V; Charron D; Mooney N
Hum Immunol; 2002 May; 63(5):375-83. PubMed ID: 11975981
[TBL] [Abstract][Full Text] [Related]
46. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
Rabinowich H; Reichert TE; Kashii Y; Gastman BR; Bell MC; Whiteside TL
J Clin Invest; 1998 Jun; 101(11):2579-88. PubMed ID: 9616229
[TBL] [Abstract][Full Text] [Related]
47. TRAIL/Apo-2-ligand-induced apoptosis in human T cells.
Jeremias I; Herr I; Boehler T; Debatin KM
Eur J Immunol; 1998 Jan; 28(1):143-52. PubMed ID: 9485194
[TBL] [Abstract][Full Text] [Related]
48. The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Acta Haematol; 2003; 110(1):1-10. PubMed ID: 12975549
[TBL] [Abstract][Full Text] [Related]
49. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
[TBL] [Abstract][Full Text] [Related]
50. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
51. Regulation of TNFRSF6 (Fas) expression in ataxia telangiectasia cells by ionizing radiation.
Albanese J; Dainiak N
Radiat Res; 2000 Dec; 154(6):616-24. PubMed ID: 11096418
[TBL] [Abstract][Full Text] [Related]
52. Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels.
Chang WK; Yang KD; Chuang H; Jan JT; Shaio MF
Clin Immunol; 2002 Aug; 104(2):151-60. PubMed ID: 12165276
[TBL] [Abstract][Full Text] [Related]
53. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells.
Drew L; Kumar R; Bandyopadhyay D; Gupta S
Int Immunol; 1998 Jul; 10(7):877-89. PubMed ID: 9701026
[TBL] [Abstract][Full Text] [Related]
55. Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression.
Mu XY; Gosland MP; Bartik MM; Schimmelpfennig J; Kay NE
J Clin Immunol; 1999 Jul; 19(4):239-46. PubMed ID: 10471978
[TBL] [Abstract][Full Text] [Related]
56. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
Sprick MR; Rieser E; Stahl H; Grosse-Wilde A; Weigand MA; Walczak H
EMBO J; 2002 Sep; 21(17):4520-30. PubMed ID: 12198154
[TBL] [Abstract][Full Text] [Related]
57. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).
Notarbartolo M; Cervello M; Dusonchet L; Cusimano A; D'Alessandro N
Cancer Lett; 2002 Jun; 180(1):91-101. PubMed ID: 11911975
[TBL] [Abstract][Full Text] [Related]
58. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.
Ebata T; Mogi S; Hata Y; Fujimoto JI; Yagita H; Okumura K; Azuma M
Eur J Immunol; 2001 May; 31(5):1410-6. PubMed ID: 11465097
[TBL] [Abstract][Full Text] [Related]
59. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
60. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
